Haemonetics Corp.
HAE
Market Cap$4.62B
Close$
$271.67
275% upside
Current Fair Value
275% upsideUndervalued by 275% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.62 Billion |
|---|---|
| Enterprise Value | $5.53 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $2.29 |
| Beta | 0.94 |
| Outstanding Shares | 50,953,098 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 39.27 |
|---|---|
| PEG | -603.85 |
| Price to Sales | 2.79 |
| Price to Book Ratio | 4.26 |
| Enterprise Value to Revenue | 4.15 |
| Enterprise Value to EBIT | 29.53 |
| Enterprise Value to Net Income | 48 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 1.39 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Haemonetics Corp.
CEO: Christopher Simon